Text Size

Telemedicine's Utility for Augmenting Clinical Trials and Informed Consent TACTIC

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Brett Meyer, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT00390286
First received: October 18, 2006
Last updated: March 1, 2012
Last verified: March 2012
History of Changes
  Purpose

This is a 6 year, Phase I, Clinical Research Protocol to study the feasibility of using a telemedicine system for performing research in a remote hospital system.


Condition Phase
Stroke
 Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Telemedicine's Utility for Augmenting Clinical Trials and Informed Consent TACTIC

Further study details as provided by University of California, San Diego:

Estimated Enrollment: 105
Study Start Date: December 2007
Estimated Study Completion Date: December 2018
Detailed Description:

The UCSD Telemedicine system is a digital video camera system, which can transfer video and audio images from a clinic or emergency room to a remote place where a physician can review images in real time (as they happen). The system uses site independent software to access the camera system from multiple locations. This research study will determine if it is feasible to obtain informed consent for various types of research trials (hypothetical, non-invasive, invasive trails) via telemedicine. Inpatient assessments on participants to complete clinical research case report forms by telemedicine will also by performed.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Acute stroke patients

Criteria

Inclusion Criteria:

  • Male/Female, age 18 years or older
  • Clinical neurological focal deficits consistent with stroke
  • Time of onset 3-24 hours and with stable neurological deficit
  • Signed Informed Consent

Exclusion Criteria:

  • Deficits known to be due to non-stroke etiology
  • Time of onset less than 3 hours
  • Patients unable to give consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00390286

Locations
United States, California
UCSD Stroke Center
San Diego, California, United States, 92103-8466
Sponsors and Collaborators
University of California, San Diego
Investigators
Principal Investigator: Brett C. Meyer, MD UCSD Medical Center
  More Information

Publications:

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Brett Meyer, MD, University of California, San Diego
ClinicalTrials.gov Identifier: NCT00390286     History of Changes
Other Study ID Numbers: 051010
Study First Received: October 18, 2006
Last Updated: March 1, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Diego:
Telemedicine

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 19, 2013